|Min SIP Amount||Not Supported|
|NAV||₹9.21 (13 Sep 2019)|
|Fund Started||11 Oct 2017|
|Fund Size||₹242 Cr|
|Alkem Laboratories Ltd.||Healthcare||Equity||1.1%|
|Dalmia Bharat Ltd.||Construction||Equity||1.1%|
|Crompton Greaves Consumer Electricals Ltd.||Cons Durable||Equity||1.1%|
|Thyrocare Technologies Ltd.||Healthcare||Equity||1.0%|
|Amber Enterprises India Ltd.||Cons Durable||Equity||0.8%|
|VRL Logistics Ltd.||Services||Equity||0.1%|
Aditya Birla Sun Life Resurgent India Fund Series 5 Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was introduced to investors on 11 Oct 2017. Jayesh Gandhi, Chanchal Khandelwal is the Current Fund Manager of Aditya Birla Sun Life Resurgent India Fund Series 5 Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹242 Cr and the Latest NAV as of 13 Sep 2019 is ₹9.21.
The Aditya Birla Sun Life Resurgent India Fund Series 5 Direct Growth is rated Moderately High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 1000. Nil.
1st Floor, Proms Complex, SBI
Colony, 1A Koramangala, 560034